Earnings Preview For Protalix BioTherapeutics
Portfolio Pulse from Benzinga Insights
Protalix BioTherapeutics (AMEX:PLX) is set to release its latest quarterly earnings report on November 6, 2023. Analysts estimate an earnings per share (EPS) of $-0.04. The company's past performance shows a pattern of beating EPS estimates, which has generally led to an increase in share price. The company's shares are currently trading at $1.69 and have seen a 79.61% increase over the last 52-week period.
November 03, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Protalix BioTherapeutics is expected to report an EPS of $-0.04. The company's history of beating EPS estimates could potentially lead to a positive impact on its share price.
Protalix BioTherapeutics has a history of beating EPS estimates, which has generally led to an increase in its share price. Given this pattern, if the company beats the EPS estimate again, it could potentially lead to a positive impact on its share price. However, it's also important to note that the company's guidance for the next quarter could also significantly affect its stock price.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100